{
    "2018-08-28": [
        [
            {
                "time": "2018-01-03",
                "original_text": "ETFs for Johnson & Johnson's Healthy Breakout",
                "features": {
                    "keywords": [
                        "Johnson",
                        "Healthy Breakout",
                        "ETFs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Pfizer Recalls Children's Advil Recall Due To Overdose Concerns",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Recall",
                        "Advil",
                        "Overdose"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Why Ionis Pharmaceuticals Stock Is Plummeting Today",
                "features": {
                    "keywords": [
                        "Ionis",
                        "Pharmaceuticals",
                        "Plummeting"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Pfizer's Tafamidis Fails to Impress in Cardiomyopathy Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Tafamidis",
                        "Cardiomyopathy",
                        "Fails"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Notable ETF Inflow Detected - IWB, UNH, PFE, CVX",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow",
                        "IWB",
                        "UNH",
                        "PFE",
                        "CVX"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug",
                "features": {
                    "keywords": [
                        "Alnylam",
                        "Investors",
                        "Pfizer",
                        "Blockbuster"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "This Is Like Buying in March 2009 and Knowing What Happens Next",
                "features": {
                    "keywords": [
                        "Buying",
                        "March 2009",
                        "Knowing"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Pfizer stock drops 2% as positive rare-disease drug results won’t stop competitors",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "stock",
                        "drops",
                        "rare-disease",
                        "competitors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Why Alnylam Pharmaceuticals Stock Rose ~16% Yesterday",
                "features": {
                    "keywords": [
                        "Alnylam",
                        "Pharmaceuticals",
                        "Stock",
                        "Rose"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "Today’s Research Reports on Stocks to Watch: Pfizer and Alnylam Pharmaceuticals",
                "features": {
                    "keywords": [
                        "Research",
                        "Reports",
                        "Pfizer",
                        "Alnylam"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-13",
                "original_text": "Why Pfizer (PFE) Stock Turned South Today",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock",
                        "South"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}